Skip to main content
Top
Published in: Virology Journal 1/2020

01-12-2020 | Influenza | Research

Influenza A virus NS1 optimises virus infectivity by enhancing genome packaging in a dsRNA-binding dependent manner

Authors: Tim Wai Sha, Michaela Weber, Dacquin M. Kasumba, Takeshi Noda, Masahiro Nakano, Hiroki Kato, Takashi Fujita

Published in: Virology Journal | Issue 1/2020

Login to get access

Abstract

Background

The non-structural protein 1 (NS1) of influenza A virus (IAV) is a key player in inhibiting antiviral response in host cells, thereby facilitating its replication. However, other roles of NS1, which are independent of antagonising host cells’ antiviral response, are less characterised.

Methods

To investigate these unidentified roles, we used a recombinant virus, which lacks NS1 expression, and observed its phenotypes during the infection of antiviral defective cells (RIG-I KO cells) in the presence or absence of exogeneous NS1. Moreover, we used virus-like particle (VLP) production system to further support our findings.

Results

Our experiments demonstrated that IAV deficient in NS1 replicates less efficiently than wild-type IAV in RIG-I KO cells and this replication defect was complemented by ectopic expression of NS1. As suggested previously, NS1 is incorporated in the virion and participates in the regulation of viral transcription and translation. Using the VLP production system, in which minigenome transcription or viral protein production was unaffected by NS1, we demonstrated that NS1 facilitates viral genome packaging into VLP, leading to efficient minigenome transfer by VLP. Furthermore, the incorporation of NS1 and the minigenome into VLP were impaired by introducing a point mutation (R38A) in the double stranded RNA-binding domain of NS1.

Conclusion

These results suggest a novel function of NS1 in improving genome packaging in a dsRNA binding-dependent manner. Taken together, NS1 acts as an essential pro-viral regulator, not only by antagonizing host immunity but also by facilitating viral replication and genome packaging.
Literature
1.
go back to reference Stasakova J, Ferko B, Kittel C, Sereinig S, Romanova J, Katinger H, Egorov A. Influenza a mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol. 2005;86(Pt 1):185–95.PubMedCrossRef Stasakova J, Ferko B, Kittel C, Sereinig S, Romanova J, Katinger H, Egorov A. Influenza a mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol. 2005;86(Pt 1):185–95.PubMedCrossRef
2.
go back to reference Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A. Influenza a virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol. 2000;74(24):11566–73.PubMedPubMedCentralCrossRef Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A. Influenza a virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol. 2000;74(24):11566–73.PubMedPubMedCentralCrossRef
3.
go back to reference Moriyama M, Chen IY, Kawaguchi A, Koshiba T, Nagata K, Takeyama H, Hasegawa H, Ichinohe T. The RNA- and TRIM25-binding domains of influenza virus NS1 protein are essential for suppression of NLRP3 Inflammasome-mediated interleukin-1beta secretion. J Virol. 2016;90(8):4105–14.PubMedPubMedCentralCrossRef Moriyama M, Chen IY, Kawaguchi A, Koshiba T, Nagata K, Takeyama H, Hasegawa H, Ichinohe T. The RNA- and TRIM25-binding domains of influenza virus NS1 protein are essential for suppression of NLRP3 Inflammasome-mediated interleukin-1beta secretion. J Virol. 2016;90(8):4105–14.PubMedPubMedCentralCrossRef
4.
go back to reference Chung WC, Kang HR, Yoon H, Kang SJ, Ting JP, Song MJ. Influenza a virus NS1 protein inhibits the NLRP3 Inflammasome. PLoS One. 2015;10(5):e0126456.PubMedCrossRef Chung WC, Kang HR, Yoon H, Kang SJ, Ting JP, Song MJ. Influenza a virus NS1 protein inhibits the NLRP3 Inflammasome. PLoS One. 2015;10(5):e0126456.PubMedCrossRef
5.
go back to reference Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza a virus NS1 protein. J Virol. 2000;74(17):7989–96.PubMedPubMedCentralCrossRef Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza a virus NS1 protein. J Virol. 2000;74(17):7989–96.PubMedPubMedCentralCrossRef
6.
go back to reference Gao S, Song L, Li J, Zhang Z, Peng H, Jiang W, Wang Q, Kang T, Chen S, Huang W. Influenza a virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell Microbiol. 2012;14(12):1849–66.PubMedCrossRef Gao S, Song L, Li J, Zhang Z, Peng H, Jiang W, Wang Q, Kang T, Chen S, Huang W. Influenza a virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell Microbiol. 2012;14(12):1849–66.PubMedCrossRef
7.
go back to reference Monteagudo PL, Munoz-Moreno R, Fribourg M, Potla U, Mena I, Marjanovic N, Hartmann BM, Sealfon SC, Garcia-Sastre A, Ramos I, Fernandez-Sesma A. Differential modulation of innate immune responses in human primary cells by influenza a viruses carrying human or avian non-structural 1 proteins. J Virol. 2019;94(1):e00999–19. Monteagudo PL, Munoz-Moreno R, Fribourg M, Potla U, Mena I, Marjanovic N, Hartmann BM, Sealfon SC, Garcia-Sastre A, Ramos I, Fernandez-Sesma A. Differential modulation of innate immune responses in human primary cells by influenza a viruses carrying human or avian non-structural 1 proteins. J Virol. 2019;94(1):e00999–19.
8.
go back to reference Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs MJ, Willart M, Ibanez LI, Hammad H, Lambrecht BN, Beyaert R, Saelens X, van Loo G. A20 deficiency in lung epithelial cells protects against influenza a virus infection. PLoS Pathog. 2016;12(1):e1005410.PubMedPubMedCentralCrossRef Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs MJ, Willart M, Ibanez LI, Hammad H, Lambrecht BN, Beyaert R, Saelens X, van Loo G. A20 deficiency in lung epithelial cells protects against influenza a virus infection. PLoS Pathog. 2016;12(1):e1005410.PubMedPubMedCentralCrossRef
9.
go back to reference Feng W, Sun X, Shi N, Zhang M, Guan Z, Duan M. Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response. Biochem Biophys Res Commun. 2017;482(4):1107–13.PubMedCrossRef Feng W, Sun X, Shi N, Zhang M, Guan Z, Duan M. Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response. Biochem Biophys Res Commun. 2017;482(4):1107–13.PubMedCrossRef
10.
go back to reference Jureka AS, Kleinpeter AB, Cornilescu G, Cornilescu CC, Petit CM. Structural basis for a novel interaction between the NS1 protein derived from the 1918 influenza virus and RIG-I. Structure. 2015;23(11):2001–10.PubMedPubMedCentralCrossRef Jureka AS, Kleinpeter AB, Cornilescu G, Cornilescu CC, Petit CM. Structural basis for a novel interaction between the NS1 protein derived from the 1918 influenza virus and RIG-I. Structure. 2015;23(11):2001–10.PubMedPubMedCentralCrossRef
11.
go back to reference Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, Garcia-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza a virus. J Virol. 2007;81(2):514–24.PubMedCrossRef Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, Garcia-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza a virus. J Virol. 2007;81(2):514–24.PubMedCrossRef
12.
go back to reference Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villan E, Garcia-Sastre A, Gack MU. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza a virus NS1 protein. PLoS Pathog. 2012;8(11):e1003059.PubMedPubMedCentralCrossRef Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villan E, Garcia-Sastre A, Gack MU. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza a virus NS1 protein. PLoS Pathog. 2012;8(11):e1003059.PubMedPubMedCentralCrossRef
13.
go back to reference Tawaratsumida K, Phan V, Hrincius ER, High AA, Webby R, Redecke V, Hacker H. Quantitative proteomic analysis of the influenza a virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor. J Virol. 2014;88(16):9038–48.PubMedPubMedCentralCrossRef Tawaratsumida K, Phan V, Hrincius ER, High AA, Webby R, Redecke V, Hacker H. Quantitative proteomic analysis of the influenza a virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor. J Virol. 2014;88(16):9038–48.PubMedPubMedCentralCrossRef
14.
go back to reference Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. Influenza a virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009;5(5):439–49.PubMedPubMedCentralCrossRef Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. Influenza a virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009;5(5):439–49.PubMedPubMedCentralCrossRef
15.
go back to reference Koliopoulos MG, Lethier M, van der Veen AG, Haubrich K, Hennig J, Kowalinski E, Stevens RV, Martin SR, Reis E, Sousa C, Cusack S, Rittinger K. Molecular mechanism of influenza a NS1-mediated TRIM25 recognition and inhibition. Nat Commun. 2018;9(1):1820–8.PubMedPubMedCentralCrossRef Koliopoulos MG, Lethier M, van der Veen AG, Haubrich K, Hennig J, Kowalinski E, Stevens RV, Martin SR, Reis E, Sousa C, Cusack S, Rittinger K. Molecular mechanism of influenza a NS1-mediated TRIM25 recognition and inhibition. Nat Commun. 2018;9(1):1820–8.PubMedPubMedCentralCrossRef
16.
go back to reference Wang Z, Robb NC, Lenz E, Wolff T, Fodor E, Pleschka S. NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J Virol. 2010;84(21):11323–35.PubMedPubMedCentralCrossRef Wang Z, Robb NC, Lenz E, Wolff T, Fodor E, Pleschka S. NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J Virol. 2010;84(21):11323–35.PubMedPubMedCentralCrossRef
17.
go back to reference Min JY, Li S, Sen GC, Krug RM. A site on the influenza a virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology. 2007;363(1):236–43.PubMedCrossRef Min JY, Li S, Sen GC, Krug RM. A site on the influenza a virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology. 2007;363(1):236–43.PubMedCrossRef
18.
go back to reference Falcon AM, Marion RM, Zurcher T, Gomez P, Portela A, Nieto A, Ortin J. Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol. 2004;78(8):3880–8.PubMedPubMedCentralCrossRef Falcon AM, Marion RM, Zurcher T, Gomez P, Portela A, Nieto A, Ortin J. Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol. 2004;78(8):3880–8.PubMedPubMedCentralCrossRef
19.
go back to reference Wang W, Krug RM. U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition of AT-AC splicing by the influenza virus NS1 protein. RNA. 1998;4(1):55–64.PubMedPubMedCentral Wang W, Krug RM. U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition of AT-AC splicing by the influenza virus NS1 protein. RNA. 1998;4(1):55–64.PubMedPubMedCentral
20.
go back to reference Aragon T, de la Luna S, Novoa I, Carrasco L, Ortin J, Nieto A. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol. 2000;20(17):6259–68.PubMedPubMedCentralCrossRef Aragon T, de la Luna S, Novoa I, Carrasco L, Ortin J, Nieto A. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol. 2000;20(17):6259–68.PubMedPubMedCentralCrossRef
21.
go back to reference de la Luna S, Fortes P, Beloso A, Ortin J. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol. 1995;69(4):2427–33.PubMedPubMedCentralCrossRef de la Luna S, Fortes P, Beloso A, Ortin J. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol. 1995;69(4):2427–33.PubMedPubMedCentralCrossRef
22.
go back to reference Hutchinson EC, Charles PD, Hester SS, Thomas B, Trudgian D, Martinez-Alonso M, Fodor E. Conserved and host-specific features of influenza virion architecture. Nat Commun. 2014;5:4816.PubMedCrossRef Hutchinson EC, Charles PD, Hester SS, Thomas B, Trudgian D, Martinez-Alonso M, Fodor E. Conserved and host-specific features of influenza virion architecture. Nat Commun. 2014;5:4816.PubMedCrossRef
23.
go back to reference Mouland AJ, Mercier J, Luo M, Bernier L, DesGroseillers L, Cohen EA. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol. 2000;74(12):5441–51.PubMedPubMedCentralCrossRef Mouland AJ, Mercier J, Luo M, Bernier L, DesGroseillers L, Cohen EA. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol. 2000;74(12):5441–51.PubMedPubMedCentralCrossRef
24.
go back to reference Tsuda Y, Isoda N, Sakoda Y, Kida H. Factors responsible for plaque formation of a/duck/Siberia/272/1998 (H13N6) influenza virus on MDCK cells. Virus Res. 2009;140(1–2):194–8.PubMedCrossRef Tsuda Y, Isoda N, Sakoda Y, Kida H. Factors responsible for plaque formation of a/duck/Siberia/272/1998 (H13N6) influenza virus on MDCK cells. Virus Res. 2009;140(1–2):194–8.PubMedCrossRef
25.
go back to reference Weber M, Sediri H, Felgenhauer U, Binzen I, Banfer S, Jacob R, Brunotte L, Garcia-Sastre A, Schmid-Burgk JL, Schmidt T, Hornung V, Kochs G, Schwemmle M, Klenk HD, Weber F. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe. 2015;17(3):309–19.PubMedPubMedCentralCrossRef Weber M, Sediri H, Felgenhauer U, Binzen I, Banfer S, Jacob R, Brunotte L, Garcia-Sastre A, Schmid-Burgk JL, Schmidt T, Hornung V, Kochs G, Schwemmle M, Klenk HD, Weber F. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe. 2015;17(3):309–19.PubMedPubMedCentralCrossRef
26.
go back to reference Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS. Reis e Sousa C, Matsuura Y, Fujita T, Akira S: differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441(7089):101–5.PubMedCrossRef Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS. Reis e Sousa C, Matsuura Y, Fujita T, Akira S: differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441(7089):101–5.PubMedCrossRef
27.
go back to reference Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. Influenza a virus lacking the NS1 gene replicates in interferon-deficient systems. Virology. 1998;252(2):324–30.PubMedCrossRef Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. Influenza a virus lacking the NS1 gene replicates in interferon-deficient systems. Virology. 1998;252(2):324–30.PubMedCrossRef
29.
go back to reference Guo L, Wang L, Yang R, Feng R, Li Z, Zhou X, Dong Z, Ghartey-Kwansah G, Xu M, Nishi M, Zhang Q, Isaacs W, Ma J, Xu X. Optimizing conditions for calcium phosphate mediated transient transfection. Saudi J Biol Sci. 2017;24(3):622–9.PubMedPubMedCentralCrossRef Guo L, Wang L, Yang R, Feng R, Li Z, Zhou X, Dong Z, Ghartey-Kwansah G, Xu M, Nishi M, Zhang Q, Isaacs W, Ma J, Xu X. Optimizing conditions for calcium phosphate mediated transient transfection. Saudi J Biol Sci. 2017;24(3):622–9.PubMedPubMedCentralCrossRef
30.
go back to reference Oh SW, Onomoto K, Wakimoto M, Onoguchi K, Ishidate F, Fujiwara T, Yoneyama M, Kato H, Fujita T. Leader-containing uncapped viral transcript activates RIG-I in antiviral stress granules. PLoS Pathog. 2016;12(2):e1005444.PubMedPubMedCentralCrossRef Oh SW, Onomoto K, Wakimoto M, Onoguchi K, Ishidate F, Fujiwara T, Yoneyama M, Kato H, Fujita T. Leader-containing uncapped viral transcript activates RIG-I in antiviral stress granules. PLoS Pathog. 2016;12(2):e1005444.PubMedPubMedCentralCrossRef
31.
go back to reference Kawakami E, Watanabe T, Fujii K, Goto H, Watanabe S, Noda T, Kawaoka Y. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J Virol Methods. 2011;173(1):1–6.PubMedCrossRef Kawakami E, Watanabe T, Fujii K, Goto H, Watanabe S, Noda T, Kawaoka Y. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J Virol Methods. 2011;173(1):1–6.PubMedCrossRef
32.
go back to reference Marc D, Barbachou S, Soubieux D. The RNA-binding domain of influenzavirus non-structural protein-1 cooperatively binds to virus-specific RNA sequences in a structure-dependent manner. Nucleic Acids Res. 2013;41(1):434–49.PubMedCrossRef Marc D, Barbachou S, Soubieux D. The RNA-binding domain of influenzavirus non-structural protein-1 cooperatively binds to virus-specific RNA sequences in a structure-dependent manner. Nucleic Acids Res. 2013;41(1):434–49.PubMedCrossRef
33.
go back to reference Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA. 1999;5(2):195–205.PubMedPubMedCentralCrossRef Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA. 1999;5(2):195–205.PubMedPubMedCentralCrossRef
34.
go back to reference Garaigorta U, Falcon AM, Ortin J. Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles. J Virol. 2005;79(24):15246–57.PubMedPubMedCentralCrossRef Garaigorta U, Falcon AM, Ortin J. Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles. J Virol. 2005;79(24):15246–57.PubMedPubMedCentralCrossRef
35.
go back to reference Salvatore M, Basler CF, Parisien JP, Horvath CM, Bourmakina S, Zheng H, Muster T, Palese P, Garcia-Sastre A. Effects of influenza a virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol. 2002;76(3):1206–12.PubMedPubMedCentralCrossRef Salvatore M, Basler CF, Parisien JP, Horvath CM, Bourmakina S, Zheng H, Muster T, Palese P, Garcia-Sastre A. Effects of influenza a virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol. 2002;76(3):1206–12.PubMedPubMedCentralCrossRef
37.
go back to reference Fortes P, Beloso A, Ortin J. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 1994;13(3):704–12.PubMedPubMedCentralCrossRef Fortes P, Beloso A, Ortin J. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 1994;13(3):704–12.PubMedPubMedCentralCrossRef
38.
go back to reference Marion RM, Zurcher T, de la Luna S, Ortin J. Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J Gen Virol. 1997;78(Pt 10):2447–51.PubMedCrossRef Marion RM, Zurcher T, de la Luna S, Ortin J. Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J Gen Virol. 1997;78(Pt 10):2447–51.PubMedCrossRef
39.
go back to reference Park YW, Katze MG. Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation. J Biol Chem. 1995;270(47):28433–9.PubMedCrossRef Park YW, Katze MG. Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation. J Biol Chem. 1995;270(47):28433–9.PubMedCrossRef
40.
go back to reference Lee MK, Kim HE, Park EB, Lee J, Kim KH, Lim K, Yum S, Lee YH, Kang SJ, Lee JH, Choi BS. Structural features of influenza a virus panhandle RNA enabling the activation of RIG-I independently of 5′-triphosphate. Nucleic Acids Res. 2016;44(17):8407–16.PubMedPubMedCentralCrossRef Lee MK, Kim HE, Park EB, Lee J, Kim KH, Lim K, Yum S, Lee YH, Kang SJ, Lee JH, Choi BS. Structural features of influenza a virus panhandle RNA enabling the activation of RIG-I independently of 5′-triphosphate. Nucleic Acids Res. 2016;44(17):8407–16.PubMedPubMedCentralCrossRef
Metadata
Title
Influenza A virus NS1 optimises virus infectivity by enhancing genome packaging in a dsRNA-binding dependent manner
Authors
Tim Wai Sha
Michaela Weber
Dacquin M. Kasumba
Takeshi Noda
Masahiro Nakano
Hiroki Kato
Takashi Fujita
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Influenza
Published in
Virology Journal / Issue 1/2020
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-020-01357-3

Other articles of this Issue 1/2020

Virology Journal 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.